Luca Leonardi

2.3k total citations
63 papers, 764 citations indexed

About

Luca Leonardi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Luca Leonardi has authored 63 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 20 papers in Neurology. Recurrent topics in Luca Leonardi's work include Genetic Neurodegenerative Diseases (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers) and Dermatological and Skeletal Disorders (10 papers). Luca Leonardi is often cited by papers focused on Genetic Neurodegenerative Diseases (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers) and Dermatological and Skeletal Disorders (10 papers). Luca Leonardi collaborates with scholars based in Italy, France and United States. Luca Leonardi's co-authors include Christian Marcotulli, Francesco Pierelli, Carlo Casali, Mariano Serrao, Antonio Petrucci, Carlo Casali, Giovanni Antonini, Alberto Ranavolo, Gianluca Coppola and Carmela Conte and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and Critical Care Medicine.

In The Last Decade

Luca Leonardi

57 papers receiving 758 citations

Peers

Luca Leonardi
Luca Leonardi
Citations per year, relative to Luca Leonardi Luca Leonardi (= 1×) peers Roberto Fernández‐Torrón

Countries citing papers authored by Luca Leonardi

Since Specialization
Citations

This map shows the geographic impact of Luca Leonardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Leonardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Leonardi more than expected).

Fields of papers citing papers by Luca Leonardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Leonardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Leonardi. The network helps show where Luca Leonardi may publish in the future.

Co-authorship network of co-authors of Luca Leonardi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Leonardi. A scholar is included among the top collaborators of Luca Leonardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Leonardi. Luca Leonardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feo, Maria Silvia De, Chiara Cambieri, Eleonora Galosi, et al.. (2025). Exploring Cardiac Sympathetic Denervation in Transthyretin-Mediated Hereditary Amyloidosis (ATTRv): Insights from 123I-mIBG Scintigraphy. Diagnostics. 15(4). 508–508.
2.
Cauquil, Cécile, Céline Labeyrie, Bruno Francou, et al.. (2025). Intracutaneous Amyloid Deposition is Associated With Nerve Conduction Studies Deterioration in Presumed Asymptomatic Pathogenic Variant TTR Carriers. European Journal of Neurology. 32(7). e70277–e70277. 1 indexed citations
3.
Primiano, Guido, Marco Luigetti, Ângela Romano, et al.. (2025). Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers. European Journal of Neurology. 32(6). e70215–e70215. 1 indexed citations
4.
Stefano, Vincenzo Di, Raffaele Iorio, Francesco Habetswallner, et al.. (2025). Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience. Journal of Neurology. 272(6). 396–396. 4 indexed citations
5.
Primiano, Guido, Angela Romano, Marco Luigetti, et al.. (2025). Peripherin, A New Promising Biomarker in Neurological Disorders. European Journal of Neuroscience. 61(4). e70030–e70030. 1 indexed citations
6.
Tozza, Stefano, Marco Luigetti, Giovanni Antonini, et al.. (2023). Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation. Frontiers in Neurology. 14. 1109782–1109782. 1 indexed citations
7.
Labeyrie, Céline, Cécile Cauquil, Bruno Francou, et al.. (2023). Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers. Journal of Neurology Neurosurgery & Psychiatry. 95(6). 489–499. 13 indexed citations
8.
Romano, Ângela, Guido Primiano, Giovanni Antonini, et al.. (2023). Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?. European Journal of Neurology. 31(1). e16070–e16070. 20 indexed citations
9.
Fionda, Laura, Luca Leonardi, Paolo Marchetti, et al.. (2023). Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors. Neurological Sciences. 45(3). 1243–1247. 6 indexed citations
10.
Luigetti, Marco, Giovanni Antonini, Andrea Di Paolantonio, et al.. (2022). Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy. European Journal of Neurology. 29(7). 2148–2155. 16 indexed citations
11.
Stefano, Vincenzo Di, Luca Gentile, Pietro Guaraldi, et al.. (2022). Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran. Pharmacogenomics and Personalized Medicine. Volume 15. 499–514. 15 indexed citations
12.
Leonardi, Luca, Clovis Adam, Guillemette Beaudonnet, et al.. (2022). Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis. European Journal of Neurology. 29(5). 1477–1487. 25 indexed citations
13.
Leonardi, Luca, Giuseppe Di Pietro, Antonella Di Pasquale, et al.. (2021). High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP. Neurological Sciences. 43(5). 3387–3394. 7 indexed citations
14.
Luigetti, Marco, Valeria Guglielmino, Giovanni Antonini, et al.. (2021). ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country. Genes. 12(6). 829–829. 14 indexed citations
15.
Leonardi, Luca, Eleonora Galosi, Fiammetta Vanoli, et al.. (2021). Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation. Neurological Sciences. 43(2). 1359–1364. 10 indexed citations
16.
Messori, Andrea, et al.. (2020). CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 20(7). 490–491. 3 indexed citations
17.
Leonardi, Luca, Fiammetta Vanoli, Laura Fionda, et al.. (2020). Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy. Neurological Sciences. 41(12). 3775–3778. 7 indexed citations
18.
Leonardi, Luca, et al.. (2017). Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans. Neurological Sciences. 39(2). 329–332. 8 indexed citations
19.
Moretta, Iolanda, et al.. (2013). The mycotic abortion in cattle.. Large animals review. 19(4). 155–161. 1 indexed citations
20.
Mignarri, Andrea, Alessandra Tessa, Alessandra Rufa, et al.. (2013). Cerebellum and neuropsychiatric disorders: insights from ARSACS. Neurological Sciences. 35(1). 95–97. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026